Quick Answer
Teladoc Health, Inc. reported Total Revenue of $2.53 billion for the year ending 2025.
- Teladoc Health, Inc. showed a decrease of -1.5% in Total Revenue from 2024 to 2025.
- This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $10.29 million | Q3 2014: $10.91 million | Q1 2015: $16.49 million | Q2 2015: $18.28 million | Q3 2015: $19.97 million | Q1 2016: $26.89 million | Q2 2016: $26.49 million | Q3 2016: $32.38 million | Q4 2016: $37.40 million | Q1 2017: $42.90 million | Q2 2017: $44.59 million | Q3 2017: $68.65 million | Q4 2017: $77.14 million | Q1 2018: $89.64 million | Q2 2018: $94.56 million | Q3 2018: $110.96 million | Q4 2018: $122.74 million | Q2 2021: $503.14 million | Q3 2021: $521.66 million | Q1 2022: $565.35 million | Q2 2022: $592.38 million | Q3 2022: $611.40 million | Q1 2023: $629.24 million | Q2 2023: $652.41 million | Q3 2023: $660.24 million | Q1 2024: $646.13 million | Q2 2024: $642.44 million | Q3 2024: $640.51 million | Q1 2025: $629.37 million | Q2 2025: $631.90 million | Q3 2025: $626.44 million.
- Over the full 12 years of available data (2013 to 2025), Teladoc Health, Inc.'s Total Revenue has grown by 12,609.6%.
- Historical annual values: Fiscal year 2025: $2.53 billion | Fiscal year 2024: $2.57 billion | Fiscal year 2023: $2.60 billion | Fiscal year 2022: $2.41 billion | Fiscal year 2021: $2.03 billion | Fiscal year 2020: $1.09 billion | Fiscal year 2018: $417.91 million | Fiscal year 2017: $233.28 million | Fiscal year 2016: $123.16 million | Fiscal year 2015: $77.38 million | Fiscal year 2014: $43.53 million | Fiscal year 2013: $19.91 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: